Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 9555951)

Published in J Lipid Res on April 01, 1998

Authors

J Saleh1, L K Summers, K Cianflone, B A Fielding, A D Sniderman, K N Frayn

Author Affiliations

1: McGill Unit for the Prevention of Cardiovascular Diseases, Royal Victoria Hospital, Montreal, Quebec, Canada.

Articles citing this

Dyslipidemia in obesity: mechanisms and potential targets. Nutrients (2013) 2.02

Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes. Obesity (Silver Spring) (2013) 1.46

Palmitic acid acutely stimulates glucose uptake via activation of Akt and ERK1/2 in skeletal muscle cells. J Lipid Res (2011) 1.04

Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics (2010) 1.04

Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J R Soc Med (2002) 1.03

Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond) (2006) 1.02

Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels. J Lipid Res (2009) 0.94

Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J (2001) 0.87

Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutr Metab (Lond) (2007) 0.85

Subcutaneous adipose tissue from obese and lean adults does not release hepcidin in vivo. ScientificWorldJournal (2011) 0.84

Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease. Pediatr Nephrol (2008) 0.84

Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice. Mediators Inflamm (2013) 0.82

The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice. BMC Physiol (2010) 0.82

Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women. Nutr Diabetes (2012) 0.80

Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women. PLoS One (2014) 0.80

Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity. Biochem J (1999) 0.79

Relationship of C5L2 receptor to skeletal muscle substrate utilization. PLoS One (2013) 0.78

Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women. Nutr Metab (Lond) (2009) 0.75

Acute effects of exogenous hormone administration on postprandial acylation stimulating protein levels in ovariectomized rats after a fat load. J Nutr Metab (2014) 0.75

Plasma gamma-glutamyltransferase is strongly determined by acylation stimulating protein levels independent of insulin resistance in patients with acute coronary syndrome. Dis Markers (2013) 0.75

Ethnic differences in acylation stimulating protein (ASP) in Xinjiang Uygur autonomous region, China. Int J Clin Exp Med (2015) 0.75

Articles by these authors

Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol (1983) 6.45

Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) (2010) 3.86

Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int (1989) 2.55

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55

Glycaemic index methodology. Nutr Res Rev (2005) 2.47

Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation (2008) 2.38

Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest (1999) 2.32

Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism (1996) 2.11

Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia (2009) 2.03

Urinary albumin excretion in school children. Arch Dis Child (1984) 1.88

Regulation of protein metabolism by a physiological concentration of insulin in mouse soleus and extensor digitorum longus muscles. Effects of starvation and scald injury. Biochem J (1979) 1.84

Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73

Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia (2002) 1.73

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia (2004) 1.65

Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab (2009) 1.65

Stability of plasma glucose during storage. Ann Clin Biochem (1990) 1.59

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med (1982) 1.53

The clinical consequences of a stiff left atrium. Am Heart J (1991) 1.52

Age of appearance of circadian rhythm in salivary cortisol values in infancy. Arch Dis Child (1983) 1.49

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) (2007) 1.49

Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol (Oxf) (1986) 1.42

Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res (1980) 1.40

Background turbidity changes during the estimation of urinary albumin. Ann Clin Biochem (1990) 1.38

Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia (2005) 1.38

Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia (2003) 1.37

The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia (2005) 1.37

Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Q J Med (1985) 1.37

The relationships between plasma substrates and hormones and the severity of injury in 277 recently injured patients. Clin Sci (Lond) (1979) 1.36

Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats. Biochem Pharmacol (1972) 1.35

Renal function in diabetes mellitus. Arch Dis Child (1985) 1.34

Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci (Lond) (1990) 1.31

Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest (1986) 1.31

Sample preparation with ion-exchange resin before liquid-chromatographic determination of plasma catecholamines. Clin Chem (1983) 1.26

Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism (1992) 1.26

Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr (1996) 1.26

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest (1993) 1.25

Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol (1994) 1.24

Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord (2003) 1.24

Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia (2008) 1.23

Mobilisation of enterocyte fat stores by oral glucose in humans. Gut (2003) 1.22

Micro-method for measurement of sub-nanomole amounts of triacylglycerol. Ann Clin Biochem (1990) 1.21

Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation (1994) 1.21

Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res (2007) 1.19

Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids (1991) 1.18

Purification and characterization of acylation stimulating protein. J Biol Chem (1989) 1.17

The use of human skeletal muscle in vitro for biochemical and pharmacological studies of glucose uptake. Clin Sci (1973) 1.17

Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes (Lond) (2009) 1.17

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. J Clin Invest (1990) 1.17

Insulin resistance, adipose tissue and coronary heart disease. Clin Sci (Lond) (1992) 1.17

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med (2001) 1.16

Effects of burn injury on insulin secretion and on sensitivity to insulin in the rat in vivo. Eur J Clin Invest (1975) 1.15

Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb (1993) 1.14

Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci (Lond) (1996) 1.13

Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond) (2006) 1.12

Lipoprotein lipase and the disposition of dietary fatty acids. Br J Nutr (1998) 1.12

Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem (1999) 1.12

Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul (1995) 1.12

Plasma catecholamines in the acute phase of the response to myocardial infarction. Arch Emerg Med (1986) 1.09

Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci U S A (1983) 1.08

Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. Lancet (1981) 1.07

Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab (1998) 1.06

Enzyme immunoassay for urinary albumin. Clin Chem (1983) 1.06

Rates of glucose utilization and glucogenesis in rats in the basal state induced by halothane anaesthesia. Biochem J (1977) 1.06

Turnover and tissue distribution of 125-I-labeled low density lipoprotein in swine and dogs. J Lipid Res (1975) 1.06

Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. Am J Physiol (1996) 1.05

The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro. Br J Pharmacol (1986) 1.05

Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology (2000) 1.05

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia (2002) 1.04

Familial aggregation and early expression of hyperapobetalipoproteinemia. Am J Cardiol (1985) 1.03

Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load. Arteriosclerosis (1986) 1.03

Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol (1989) 1.03

Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation (1993) 1.03

Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res (1990) 1.01

The effect of sepsis on the oxidation of carbohydrate and fat. Br J Surg (1983) 1.01

Enhanced dietary fat clearance in postobese women. J Lipid Res (2001) 1.01

Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res (2000) 1.00

Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia (2007) 1.00

Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism (1993) 0.99

Arteriovenous differences across human adipose and forearm tissues after overnight fast. Metabolism (1990) 0.99

Does the DASH diet lower blood pressure by altering peripheral vascular function? J Hum Hypertens (2009) 0.98

Paradoxical increase in rate of catabolism of low-density lipoproteins after hepatectomy. Science (1974) 0.98

Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologia (2007) 0.97

Within- and between-subject variation in commonly measured anthropometric and biochemical variables. Clin Chem (1999) 0.97

Modification and validation of a commercially available portable detector for measurement of adipose tissue blood flow. Clin Physiol (1995) 0.97

The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem Cell Biol (2007) 0.96